Efficacy and safety of guanfacine extended-release in Japanese adults with attention-deficit/hyperactivity disorder: Exploratory post hoc subgroup analyses of a randomized, double-blind, placebo-controlled study.
Neuropsychopharmacol Rep. 2021 Mar;41(1):26-39. doi: 10.1002/npr2.12152. Epub 2020 Dec 10.
Neuropsychopharmacol Rep. 2021.
PMID: 33305542
Free PMC article.
Clinical Trial.